Previous work using immunohistochemistry has shown that the expression of FOXA1 [10,31,33] and of GATA-3 [9,34,37] is in close association with ERα expression in breast cancer, highlighting their prognostic and predictive value in this malignancy. This evidence concerns the gene FOXA1 and breast carcinoma.